In the bleomycin-induced mouse pulmonary fibrosis model, IL-4 and IL-13 levels were significantly increased, but after blocking the IL-4/IL-13 signaling pathway, the activation of STAT6 was reduced and which could significantly ameliorate pulmonary fibrosis [57]. The gene discussed is STAT6; the disease is pulmonary fibrosis.